Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1024-2018

Drug recall · August 8, 2018

Doxycycline Hyclate Tablets recall

Why: Failed Dissolution Specifications:

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Doxycycline Hyclate Tablets, USP, 100 mg*. 50-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-50.

Lots / codes

Lot# 71545B, Expiry date: 01/19

Quantity
29,048 bottles (1,452,400 tablets)
Company
West-Ward Columbus Inc, Columbus, OH
Distribution
Nationwide in the USA.
Initiated
July 24, 2018 · Voluntary: Firm initiated
Classified
August 2, 2018
Reported
August 8, 2018
Ended
April 29, 2020
How notified
N/A

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Doxycycline

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.